share_log

艾美疫苗：(經修訂) 截至二零二三年十二月三十一日止之股份發行人的證券變動月報表

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Hong Kong Stock Exchange ·  May 7 16:38
Summary by Futu AI
艾美疫苗股份有限公司於2024年5月7日重新提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的H股和內資股在該月份均無增減，H股結存為492,173,711股，內資股結存為718,888,888股。此外，公司首次公開發售前的僱員股份激勵計劃在本月內取消了4,468,000股份期權，使得本月底結存的股份期權數為3,351,000股。艾美疫苗確認所有發行的證券均已獲得董事會正式授權批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
艾美疫苗股份有限公司於2024年5月7日重新提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的H股和內資股在該月份均無增減，H股結存為492,173,711股，內資股結存為718,888,888股。此外，公司首次公開發售前的僱員股份激勵計劃在本月內取消了4,468,000股份期權，使得本月底結存的股份期權數為3,351,000股。艾美疫苗確認所有發行的證券均已獲得董事會正式授權批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
EMERY VACCINES CO., LTD. REFILED ON MAY 7, 2024 ITS REPORT OF MONTHLY CHANGES IN SECURITIES FOR THE YEAR ENDED DECEMBER 31, 2023. The report showed that the company's H shares and inward capital shares did not decrease during the month, with 492,173,711 shares outstanding and 718,888,888 shares outstanding. In addition, the company's Employee Stock Incentive Program prior to its initial public offering canceled 4,468,000 share options during the month, bringing the number of stock options outstanding at the end of the month to 3,351,000 shares. AMIE CONFIRMS THAT ALL SECURITIES ISSUED HAVE BEEN FORMALLY AUTHORIZED BY THE BOARD OF DIRECTORS AND COMPLY WITH THE RELEVANT REQUIREMENTS OF THE SECURITIES LISTING RULES OF THE HONG KONG STOCK EXCHANGE LIMITED.
EMERY VACCINES CO., LTD. REFILED ON MAY 7, 2024 ITS REPORT OF MONTHLY CHANGES IN SECURITIES FOR THE YEAR ENDED DECEMBER 31, 2023. The report showed that the company's H shares and inward capital shares did not decrease during the month, with 492,173,711 shares outstanding and 718,888,888 shares outstanding. In addition, the company's Employee Stock Incentive Program prior to its initial public offering canceled 4,468,000 share options during the month, bringing the number of stock options outstanding at the end of the month to 3,351,000 shares. AMIE CONFIRMS THAT ALL SECURITIES ISSUED HAVE BEEN FORMALLY AUTHORIZED BY THE BOARD OF DIRECTORS AND COMPLY WITH THE RELEVANT REQUIREMENTS OF THE SECURITIES LISTING RULES OF THE HONG KONG STOCK EXCHANGE LIMITED.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.